Antiplatelet therapy is associated with a high rate of intracranial hemorrhage in patients with head injuries

BACKGROUND: Antiplatelet agents are increasingly used in cardiovascular treatment. Limited research has been performed into risks of acute and delayed traumatic intracranial hemorrhage (ICH) in these patients who sustain head injuries. Our goal was to assess the overall odds and identify factors ass...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Trauma Surg Acute Care Open
Autors principals: Alter, Scott M, Mazer, Benjamin A, Solano, Joshua J, Shih, Richard D, Hughes, Mary J, Clayton, Lisa M, Greaves, Spencer W, Trinh, Nhat Q, Hughes, Patrick G
Format: Artigo
Idioma:Inglês
Publicat: BMJ Publishing Group 2020
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7689589/
https://ncbi.nlm.nih.gov/pubmed/33294625
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/tsaco-2020-000520
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars